A Layer Plus Approach to Implementation Research and Collaboration for Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention.
In 2020, the HIV prevention clinical trials, HPTN (HIV Prevention Trials Network) 083 and 084, reported that long-acting injectable cabotegravir (CAB-LA) for HIV prevention was statistically superior to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (Pr...
| Publicado en: | Health Promotion Practice Vol. 23; no. 6; pp. 912 - 916 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial Journal Article |
| Publicado: |
Sage Publications Inc.
Nov2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |